Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.
The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback